News
- Advocacy, News
Fifty-five years after its adoption, the 1971 United Nations Convention on Psychotropic Substances continues to function as the backbone of the international regime that restricts access to compounds such as DMT, psilocybin, and mescaline. Most national legislation, clinical research frameworks,
Latest News
- Articles, Guest Voices
Ibogaine, one of the active principles of iboga, was available as a medicine in French pharmacies forty years before LSD. This little-known history was shared by José Carlos Bouso, ICEERS’ Scientific Director, at the recent Horizons PBC conference in New
Latest Report
- Reports
The legal framework surrounding ayahuasca in Portugal is complex and nuanced. It reflects a broader global conversation occurring on the intersection of traditional practices, religious freedom, and drug policy. The history of ayahuasca in the country has been influenced by
Latest Study
- Ayahuasca, Studies, Studies & papers
A prospective, longitudinal study led by ICEERS researchers evaluated the psychological effects of ayahuasca retreats conducted by Shipibo healers in the Peruvian Amazon. Findings indicate significant improvements in quality of life and decentering capacity, reductions in neuroticism, and long-term benefits